Table 1.

Participant-reported Global Impression of Change by lesion reduction at week 12

Efficacy	Vehicle once daily (N = 447)		Berdazimer gel, 10.3% once daily (N = 444)		Total (N = 891)
	Improvement (n = 331)	No improvement (n = 63)	Improvement (n = 371)	No improvement (n = 21)	Improvement (n = 702)	No improvement (n = 84)
Patients with ≥ 75% reduction from baseline in MC lesion count	141	0	232	3	373	3
Patients with ≥ 90% reduction from baseline in MC lesion count	106	0	189	1	295	1

MC molluscum contagiosum